Document:

EQUITY LINE OF CREDIT AGREEMENT

       AGREEMENT dated as of the 14th day of March 2001, (the "Agreement") between Cornell
Capital Partners, L.P. (the "Investor"), a Delaware limited partnership, the address of which shall be
set forth on Schedule I to this Agreement, and PACEL CORP., a corporation organized and existing
under the laws of the Commonwealth of Virginia (the "Company").

       WHEREAS, the parties desire that, upon the terms and subject to the conditions contained
herein, the Company may issue and sell to the Investor, from time to time as provided herein, and
the Investor shall purchase, shares of the Company's common stock, no par value, (the "Common
Stock"), for a total purchase price of up to Ten Million ($10,000,000) Dollars; and

       WHEREAS, such investments will be made in reliance upon the provisions of Regulation
D ("Regulation D") promulgated under the Securities Act, and the regulations promulgated
thereunder, and or upon such other exemption from the registration requirements of the Securities
Act as may be available with respect to any or all of the investments to be made hereunder; and

       NOW, THEREFORE, the parties hereto agree as follows:

ARTICLE I
Certain Definitions

       Section 1.1       	"Advance" shall mean the portion of the Commitment
Amount requested by the Company in the Advance Notice.

       Section 1.2       "Advance Closing" shall mean one of the closings of a purchase and sale
of Common Stock pursuant to Section 2.1.

       Section 1.3       "Advance Closing Date" shall mean the date of an Advance Closing.

       Section 1.4       "Advance Notice Date" shall mean each date on which the Company
delivers to the Investor an Advance Notice requiring the Investor to advance funds to the
Company subject to the terms of this Agreement.  No Advance Notice Date shall be less than ten
(10) Trading Days after the prior Advance Notice Date.

       Section 1.5       "Advance Date" shall mean the date McGuireWoods LLP Escrow Account
is in receipt of the funds from the Investor and McGuireWoods LLP, as escrow agent, is in
possession of free trading shares from the Company and therefore an Advance can be made and
McGuireWoods LLP can release the free trading shares to the Investor. No Advance Date shall
be less than ten (10) Trading Days after an Advance Notice Date or less than twelve (12) Trading
Days after a previous Advance Date.  

1NEXT PAGE

       Section 1.6       "Advance Notice" shall mean a notice to the Investor from the Company
setting forth the Advance that the Company requests from the Investor and the proposed
Advance Date, for such Advance, substantially in the form of Exhibit D annexed hereto.

       Section 1.7       "Average Daily Volume" shall be computed using the forty (40) trading
days prior to the respective Advance Date.

       Section 1.8       "Bid Price" shall mean, on any date, the closing bid price (as reported by
Bloomberg L.P.) of the Common Stock on the Principal Market or if the Common Stock is not
traded on a Principal Market, the highest reported bid price for the Common Stock, as furnished
by the National Association of Securities Dealers, Inc.

       Section 1.9       "Commitment Amount" shall mean the aggregate amount of up to
$10,000,000, which the Investor has agreed to provide to the Company in order to purchase the
Company's Common Stock pursuant to the terms and conditions of this Agreement.

       Section 1.10       "Commitment Period" shall mean the period commencing on the earlier to
occur of (i) the Effective Date, or (ii) such earlier date as the Company and the Investor may
mutually agree in writing, and expiring on the earliest to occur of (x) the date on which the
Investor shall have made Advances pursuant to this Agreement in the aggregate amount of
$10,000,000, (y) the date this Agreement is terminated pursuant to Section 2.5, or (z) the date
occurring thirty  (30) months from the Effective Date.

       Section 1.11       "Common Stock" shall mean the Company's common stock, no par value.

       Section 1.12       "Condition Satisfaction Date" shall have the meaning set forth in Section
7.2.

       Section 1.13       "Damages" shall mean any loss, claim, damage, liability, costs and
expenses (including, without limitation, reasonable attorney's fees and disbursements and costs
and expenses of expert witnesses and investigation).

       Section 1.14       "Effective Date" shall mean the date on which the SEC first declares the
Registration Statement, thereby effective, registering the resale of the Registrable Securities as
set forth in Section 7.2(a). 

       Section 1.15       "Escrow Agent" shall mean the escrow agent acting under Escrow
Agreement.

       Section 1.16       "Escrow Agreement" shall mean the Escrow Agreement, dated the date
hereof, among the Company, the Investor and the Escrow Agent named therein, substantially in
the form of Exhibit B annexed hereto.

       Section 1.17       "Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder.

2NEXT PAGE

       Section 1.18       "Material Adverse Effect" shall mean any condition, circumstance, or
situation that would prohibit or otherwise materially interfere with the ability of the Company to
enter into and perform any of its obligations under this Agreement or the Registration Rights
Agreement in any material respect.

       Section 1.19       "Market Price" shall mean the lowest closing Bid Price of the Common
Stock reported during the Pricing Period.

       Section 1.20       "Maximum Advance Amount"  shall be equal to one hundred and fifty
percent  (150%) of the Average Daily Volume of the Common Stock, multiplied by the Purchase
Price, as determined for the Pricing Period that ends on the same Trading Day as the 40-day
period during which the Average Daily Volume is being determined. 

       Section 1.21       "NASD" shall mean the National Association of Securities Dealers, Inc.

       Section 1.22       "Person" shall mean an individual, a corporation, a partnership, an
association, a trust or other entity or organization, including a government or political
subdivision or an agency or instrumentality thereof.

       Section 1.23       "Placement Agent" shall mean Yorkville Advisors, LLC, a Delaware
limited liability company.

       Section 1.24       "Pricing Period" shall mean the ten (10) Trading Day period beginning on
the Advance Notice Date and ending on the Trading Day immediately prior to the Advance
Closing Date of the respective Advance.

       Section 1.25       "Principal Market" shall mean the Nasdaq National Market, the Nasdaq
SmallCap Market, the American Stock Exchange or the New York Stock Exchange, whichever is
at the time the principal trading exchange or market for the Common Stock.

       Section 1.26       "Purchase Price", as to any Pricing Period, shall be set at 91% of the
Market Price for the same Pricing Period.

       Section 1.27       "Registrable Securities" shall mean the shares of Common Stock (i) in
respect of which the Registration Statement has not been declared effective, or if declared
effective has thereafter been suspended, by the SEC, (ii) which have not been sold under
circumstances meeting all of the applicable conditions of Rule 144 (or any similar provision then
in force) under the Securities Act ("Rule 144") or (iii) which have not been otherwise transferred
to a holder who may trade such shares without restriction under the Securities Act, and the
Company has delivered a new certificate or other evidence of ownership for such securities not
bearing a restrictive legend.

       Section 1.28       "Registration Rights Agreement" shall mean the Registration Rights
Agreement, dated the date hereof, between the Investor and the Company regarding the filing of
the

3NEXT PAGE

Registration Statement for the resale of the Registrable Securities, entered into between the
Company and the Investor, substantially in the form of Exhibit A annexed hereto.

       Section 1.29       "Registration Statement" shall mean a registration statement on Form SB-1 or Form S-3 (if use of such form is then available to the Company pursuant to the
rules of the
SEC and, if not, on such other form promulgated by the SEC for which the Company then
qualifies and which counsel for the Company shall deem appropriate, and which form shall be
available for the resale of the Registrable Securities to be registered thereunder in accordance
with the provisions of this Agreement and the Registration Rights Agreement, and in accordance
with the intended method of distribution of such securities), for the registration of the resale by
the Investor of the Registrable Securities under the Securities Act.

       Section 1.30        "Regulation D" shall have the meaning set forth in the recitals of this
Agreement.

       Section 1.31        "SEC" shall mean the U.S. Securities and Exchange Commission.

       Section 1.32       "Securities Act" shall mean the Securities Act of 1933, as amended.

       Section 1.33       "Securities Purchase Agreement" shall mean the Securities Purchase
Agreement, dated the date hereof, between the Company and the Purchasers named therein.

       Section 1.34        "SEC Documents" shall mean Annual Reports on Form 10-KSB,
Quarterly Reports on Form 10-QSB, Current Reports on Form 8-K and Proxy Statements of the
Company as supplemented to the date hereof, filed by the Company for a period of at least
twelve (12) months immediately preceding the date hereof or the Advance Date, as the case may
be, until such time as the Company no longer has an obligation to maintain the effectiveness of
the Registration Statement as set forth in the Registration Rights Agreement.

       Section 1.35       "Trading Day" shall mean any day during which the New York Stock
Exchange shall be open for business.

ARTICLE II

Advances

       Section 2.1       Advances.

       Upon the terms and conditions set forth herein (including without limitation, the
provisions of Article VII), on any Advance Notice Date the Company may request an Advance
by the Investor by the delivery of an Advance Notice.  The number of shares of Common Stock
that the Company shall issue to the Investor in exchange for the respective Advance shall be
determined by dividing

4NEXT PAGE

the amount of the Advance requested by the Advance Notice by the
Purchase Price on the respective Advance Notice Date.  No fractional shares shall be issued in
response to any Advance Notice, and fractional shares resulting therefrom shall be rounded to the
next higher whole number of shares.  The aggregate maximum amount of all Advances that the
Investor shall be obligated to make under this Agreement shall not exceed $5,000,000 until such
time as the Company has complied with the condition set forth in Section 7.3.

       Section 2.2       Mechanics.

              (a)       Advance Notice.  At any time during the Commitment Period, the
Company may deliver an Advance Notice to the Investor, subject to the conditions set forth in
Section 2.7 and Section 7.2; provided, that, the amount for each Advance as designated by the
Company in the applicable Advance Notice shall not be more than the Maximum Advance
Amount applicable to the period ending on the Trading Day immediately prior to the applicable
Advance Notice Date.  The aggregate amount of the Advances pursuant to this Agreement shall
not exceed the Commitment Amount, unless otherwise agreed by the Investor in the Investor's
sole and absolute discretion.  There will be a minimum of  ten (10) Trading Days between any
two (2) Advance Notice Dates.  

              (b)	       Date of Delivery of Advance Notice.  An Advance Notice shall be deemed
delivered on (i) the Trading Day it is received by facsimile or otherwise by the Investor if such
notice is received prior to 12:00 noon Eastern Time, or (ii) the immediately succeeding Trading
Day if it is received by facsimile or otherwise after 12:00 noon Eastern Time on a Trading Day
or at any time on a day which is not a Trading Day.  No Advance Notice may be deemed
delivered on any day that is not a Trading Day.

       Section 2.3       Advance Closings.  At the Advance Closing held on each Advance Date,
which shall be ten (10) Trading Days after an Advance Notice Date, (i) the Company shall
deliver to the Escrow Agent under the Escrow Agreement, shares of the Company's Common
Stock representing the amount of the Advance by the Investor pursuant to Section 2.1, registered
in the name of the Investor which shall be delivered to the Investor, or otherwise in accordance
with the Escrow Agreement, and (ii) the Investor shall deliver to the Escrow Agent the amount of
the Advance specified in the Advance Notice by wire transfer of immediately available funds
which shall be delivered to the Company, or otherwise, in accordance with the Escrow
Agreement.  In addition, on or prior to the Advance Date, each of the Company and the Investor
shall deliver to the other through the Escrow Agent all documents, instruments and writings
required to be delivered or reasonably requested by either of them pursuant to this Agreement in
order to implement and effect the transactions contemplated herein.  Payment of funds to the
Company and delivery of the Company's Common Stock to the Investor shall occur in
accordance with the conditions set forth above and those contained in the Escrow Agreement;
provided, that to the extent the Company has not paid the fees, expenses, and disbursements of
the Investor's counsel and the Placement Agent in accordance with Section 12.4, the amount of
such fees, expenses, and disbursements may be deducted by the Investor (and shall be paid to the
relevant party) from the amount of the Advance

5NEXT PAGE

 with no reduction in the amount of shares of the
Company's Common Stock to be delivered on such Advance Date.

       Section 2.4       Suspension of Registration Statement.  If subsequent to any Advance
Closing, the Registration Statement is suspended or becomes subject to a stop order, other than
due to the acts of the Investor or the Placement Agent, for any period exceeding twenty (20)
Trading Days, the Company shall pay an amount equal to  two percent (2 %)  of the Purchase
Price of all Common Stock held by the Investor purchased pursuant to this Agreement for each
twenty (20) Trading Day period or portion thereof; provided, that the Company shall not be
required to pay such amount to the Investor in connection with any period commencing upon the
filing of a post-effective amendment to such Registration Statement and ending upon the date on
which such post-effective amendment is declared effective by the SEC. 

       Section 2.5       Termination of Investment.  

              (a)       The obligation of the Investor to make an Advance to the Company
pursuant to this Agreement shall terminate permanently (including with respect to an Advance
Date that has not yet occurred) if (i) there shall occur any stop order or suspension of the
effectiveness of the Registration Statement for an aggregate of thirty (30) Trading Days, other
than due to the acts of the Investor or the Placement Agent, during the Commitment Period or (ii)
the Company shall at any time fail materially to comply with the requirements of Section 6.3, 6.4
or 6.7; provided, that this termination provision shall not apply to any period commencing upon
the filing of a post-effective amendment to such Registration Statement and ending upon the date
on which such post effective amendment is declared effective by the SEC. 

              (b)       Notwithstanding the provisions of this Agreement, if the Company does
not receive an Advance from the Investor pursuant to an Advance Notice calculated as
determined herein, within the time prescribed herein, this Agreement can be terminated at the
discretion of the Company, unless otherwise agreed by the parties, or  if during any ninety (90)
day period the Company cannot supply the Investor with an Advance Notice pursuant to this
Agreement.

       Section 2.6       Agreement to Advance Funds.

       (a)	The Investor will advance the amount specified in the Advance Notice to
the Company after the completion of each of the following conditions and the other conditions
set forth in this Agreement:  

(i)	the execution and delivery by the Company, and the Investor, of
this Agreement, and the Exhibits hereto;

(ii)	the Placement Agent's Counsel shall have received the shares of
Common Stock applicable to the Advance;

 

6NEXT PAGE

(iii)	the Company's Registration Statement with respect to the resale of
the Registrable Securities in accordance with the terms of the Registration Rights
Agreement shall have been declared effective by the SEC and no stop order
relating thereto shall be in effect;

(iv)	the Company shall have obtained all permits and qualifications
required by any applicable state for the offer and sale of the Registrable
Securities, or shall have the availability of exemptions therefrom.  The sale and
issuance of the Registrable Securities shall be legally permitted by all laws and
regulations to which the Company is subject;

(v)	the Company shall have filed with the SEC within the time periods
required by the SEC's regulations all reports, notices and other documents
required under the Exchange Act and applicable SEC regulations;

(vi)	the fees as set forth in Section 12.4 shall have been paid; and

(vii)
the conditions set forth in Section 7.2 shall have been satisfied.

       (b)       Notwithstanding any other provision of this Agreement to the contrary, (i)
unless otherwise permitted by the Principal Market, at no time will the Company request an
Advance that would result in the issuance to the Investor of an aggregate number of shares of the
Common Stock which exceeds 19.9% of the number of shares of the Common Stock issued and
outstanding on the initial Advance Closing Date without obtaining stockholder approval of such
excess issuance, and (ii) the Company may not deliver an Advance Notice to the extent that, after
such purchase by the Investor, the sum of the number of shares of the Common Stock
beneficially owned by the Investor and its affiliates would result in beneficial ownership by the
Investor and its affiliates of more than 9.9% of the then outstanding shares of the Common
Stock. For purposes of the immediately preceding sentence, beneficial ownership shall be
determined in accordance with Section 13(d) of the Exchange Act.

       Section 2.7       Registration Sales of Shares; Lock-Up Period.       (a)       During the
Commitment Period, the Company shall not, without the prior consent of the Investor, issue or
sell (i) any Common Stock without consideration or for a consideration per share less than the
Bid Price on the date of issuance other than in connection with up to $500,000 of convertible
debentures which will be convertible at discounts to the Bid Price, or (ii) issue or sell any
warrant, option, right, contract, call, or other security or instrument granting the holder thereof
the right to acquire Common Stock without consideration or for a consideration per share less
than the Bid Price on the date of issuance.  Exceptions to this are (a) private transactions where
shares are sold or issued that are not permitted, under any circumstances for a period of at least
one (1) year, and (b) shares issued under stock option plans authorized by the Company and its
stockholders.

              (b)	       On the date of this Agreement the Company shall obtain from each officer,
director and Affiliate, as defined below, a lock-up agreement, as defined below, in the form
annexed

7NEXT PAGE

hereto as Schedule 2.7(a) agreeing to only sell in compliance with the volume limitation
of Rule 144. As used herein, "Affiliate" shall have the meaning given it under Rule 405
promulgated under the Securities Act.

       Section 2.8       Shareholder Approval.	To the extent that the Company's
obligations under this Agreement are subject to approval of the shareholders of the Company
pursuant to the Virginia Business Corporation Law, which approval will be duly obtained prior
to the first Advance Date.

ARTICLE III

Representations and Warranties of Investor

       Investor hereby represents and warrants to, and agrees with, the Company that the following
are true and as of the date hereof and as of each Advance Closing Date:

       Section 3.1       Organization and Authorization.  Investor is duly incorporated or
organized and validly existing in the jurisdiction of its incorporation or organization and has all
requisite power and authority to purchase and hold the securities issuable hereunder.  The
decision to invest and the execution and delivery of this Agreement by the Investor, the
performance by such Investor of its obligations hereunder and the consummation by the Investor
of the transactions contemplated hereby have been duly authorized and requires no other
proceedings on the part of the Investor.  The Investor has the right, power and authority to
execute and deliver this Agreement and the Registration Rights Agreement).  This Agreement
has been duly executed and delivered by the Investor and, assuming the execution and delivery
hereof and acceptance thereof by the Company, will constitute the legal, valid and binding
obligations of the Investor, enforceable against the Investor in accordance with its terms, except
as such enforceability may be limited by general principles of equity or by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or
affecting generally, the enforcement of creditors' rights and remedies.

       Section 3.2       Evaluation of Risks.  The Investor has such knowledge and experience in
financial tax and business matters as to be capable of evaluating the merits and risks of, and
bearing the economic risks entailed by, an investment in the Company and of protecting its
interests in connection with this transaction.  It recognizes that its investment in the Company
involves a high degree of risk.

       Section 3.3       No Legal Advice from the Company.  The Investor acknowledges that it
had the opportunity to review this Agreement and the transactions contemplated by this
Agreement with its own legal counsel and investment and  tax advisors.  The Investor is relying
solely on such counsel and advisors and not on any statements or representations of the Company
or any of its representatives or agents for legal, tax or investment advice with respect to this
investment, the transactions contemplated by this Agreement or the securities laws of any
jurisdiction.

8NEXT PAGE

       Section 3.4       Investment Purpose. The securities are being purchased by the Investor for
its own account, for investment and without any view to the distribution, assignment or resale to
others or fractionalization in whole or in part.  The Investor agrees not to assign or in any way
transfer the Investor's rights to the securities or any interest therein and acknowledges that the
Company will not recognize any purported assignment or transfer except in accordance with
applicable Federal and state securities laws.  No other person has or will have a direct or indirect
beneficial interest in the securities.  The Investor agrees not to sell, hypothecate or otherwise
transfer the Investor's securities unless the securities are registered under Federal and applicable
state securities laws or unless, in the opinion of counsel satisfactory to the Company, an
exemption from such laws is available.

       Section 3.5       Accredited Investor.  Investor is an "accredited investor" as that term is
defined in Regulation D.

       Section 3.6       Information. The Investor  and its advisors (and his or its counsel), if any,
have been furnished with all materials relating to the business, finances and operations of the
Company and information it deemed material to making an informed investment decision.  The
Investor and its advisors, if any, have been afforded the opportunity to ask questions of the
Company and its management.  Neither such inquiries nor any other due diligence investigations
conducted by such Investor or its advisors, if any, or its representatives shall modify, amend or
affect the Investor's right to rely on the Company's representations and warranties contained in
this Agreement. Such Investor understands that its investment involves a high degree of risk.  

       Section 3.7       Receipt of Documents. The Investor and its counsel has received and read
in their entirety:  (i) this Agreement and the Exhibits annexed hereto; (ii) all due diligence and
other information necessary to verify the accuracy and completeness of such representations,
warranties and covenants; (iii) the Company's Form 10-KSB for the year ended year ended
December 31, 1999 and Form 10-QSB for the periods ended March 31, June 30 and September
30, 2000; and (iv) answers to all questions the Investor submitted to the Company regarding an
investment in the Company. The Investor has relied on the information contained therein and has
not been furnished any other documents, literature, memorandum or prospectus.

       Section 3.8       Registration Rights Agreement and Escrow Agreement.  The Investor and
the Company have duly executed and delivered the Registration Rights Agreement and the
Escrow Agreement.  

       Section 3.9       No General Solicitation.  Neither the Company, nor any of its affiliates,
nor any person acting on its or their behalf, has engaged in any form of general solicitation or
general advertising (within the meaning of Regulation D) in connection with the offer or sale of
the shares of Common Stock offered hereby.

       Section 3.10       Not an Affiliate.  The Investor is not an Affiliate of the company.

9NEXT PAGE

ARTICLE IV

Representations and Warranties of the Company

       Except as stated below or on the disclosure schedules attached hereto, the Company hereby
represents and warrants to, and covenants with, the Investor that the following are true and correct
as of the date hereof and as of each Advance Closing Date:

       Section 4.1       Organization and Qualification.  The Company is duly incorporated or
organized and validly existing in the jurisdiction of its incorporation or organization and has all
requisite power and authority corporate power to own their properties and to carry on their
business as now being conducted.  Each of the Company and its subsidiaries is duly qualified as
a foreign corporation to do business and is in good standing in every jurisdiction in which the
nature of the business conducted by it makes such qualification necessary, except to the extent
that the failure to be so qualified or be in good standing would not have a Material Adverse
Effect on the Company and its subsidiaries taken as a whole.

       Section 4.2       Authorization, Enforcement, Compliance with Other Instruments.   (i) The
Company has the requisite corporate power and authority to enter into and perform this
Agreement, the Registration Rights Agreement and any related agreements, in accordance with
the terms hereof and thereof; (ii) the execution and delivery of this Agreement, the Registration
Rights Agreement, the Escrow Agreement and any related agreements by the Company and the
consummation by it of the transactions contemplated hereby and thereby, have been duly
authorized by the Company's Board of Directors and no further consent or authorization is
required by the Company, its Board of Directors or its stockholders; (iii) except as disclosed in
Section 4.3, this Agreement, the Registration Rights Agreement, the Escrow Agreement and any
related agreements have been duly executed and delivered by the Company; and (iv) under this
Agreement, the Registration Rights Agreement, Escrow Agreement and any related agreements
constitute the valid and binding obligations of the Company enforceable against the Company in
accordance with their terms, except as such enforceability may be limited by general principles
of equity or by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of creditors' rights and remedies. 

       Section 4.3       Capitalization.  As of the date hereof, the authorized capital stock of the
Company consists of 5,000,000 shares of Preferred Stock, no par value, of which 1,000,000
shares are issued and outstanding, and 150,000,000 shares of Common Stock, no par value, of
which 48,380,664 shares are issued and outstanding.  All of such outstanding shares of preferred
stock and of the Common Stock have been validly issued and are fully paid and nonassessable.
Except as disclosed on Schedule 4.3, no shares of Common Stock are subject to preemptive
rights or any other similar rights or any liens or encumbrances suffered or permitted by the
Company.  Except as disclosed on Schedule 4.3, as of the date hereof, (i) there are no
outstanding options, warrants, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, or contracts, commitments, understandings or arrangements
by which the Company or any of its subsidiaries is or

10NEXT PAGE

may become bound to issue additional
shares of capital stock of the Company or any of its subsidiaries or options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities or
rights convertible into, any shares of capital stock of the Company or any of its subsidiaries, (ii)
there are no outstanding debt securities and (iii) there are no agreements or arrangements under
which the Company or any of its subsidiaries is obligated to register the sale of any of their
securities under the Securities Act (except pursuant to the Registration Rights Agreement).
There are no securities or instruments containing anti-dilution or similar provisions that will be
triggered in this Agreement or any related agreement or the consummation of the transactions
described herein or therein.  The Company has furnished to the Investor true and correct copies
of the Company's Articles of Incorporation, as amended and as in effect on the date hereof (the
"Articles of Incorporation"), and the Company's By-laws, as in effect on the date hereof (the
"By-laws"), and the terms of all securities convertible into or exercisable for Common Stock and
the material rights of the holders thereof in respect thereto.

       Section 4.4       No Conflict.  Subject to Sections 2.8 and 7.3, the execution, delivery and
performance of this Agreement by the Company and the consummation by the Company of the
transactions contemplated hereby will not (i) result in a violation of the Articles of Incorporation,
any certificate of designations of any outstanding series of preferred stock of the Company or
By-laws or (ii) conflict with or constitute a default (or an event which with notice or lapse of
time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the
Company or any of its subsidiaries is a party, or result in a violation of any law, rule, regulation,
order, judgment or decree (including federal and state securities laws and regulations and the
rules and regulations of the Principal Market) applicable to the Company or any of its
subsidiaries or by which any property or asset of the Company or any of its subsidiaries is bound
or affected.  Except as set forth in Schedule 4.4, neither the Company nor its subsidiaries is in
violation of any term of or in default under its Certificate of Incorporation or By-laws or their
organizational charter or by-laws, respectively, or any material contract, agreement, mortgage,
indebtedness, indenture, instrument, judgment, decree or order or any statute, rule or regulation
applicable to the Company or its subsidiaries.  The business of the Company and its subsidiaries
is not being conducted, and shall not be conducted in violation of any material law, ordinance,
regulation of any governmental entity.  Except as specifically contemplated by this Agreement
and as required under the Securities Act and any applicable state securities laws, the Company is
not required to obtain any consent, authorization or order of, or make any filing or registration
with, any court or governmental agency in order for it to execute, deliver or perform any of its
obligations under or contemplated by this Agreement or the Registration Rights Agreement in
accordance with the terms hereof or thereof.  All consents, authorizations, orders, filings and
registrations which the Company is required to obtain pursuant to the preceding sentence have
been obtained or effected on or prior to the date hereof.  The Company and its subsidiaries are
unaware of any facts or circumstance which might give rise to any of the foregoing.

       Section 4.5       SEC Documents; Financial Statements. The Company has filed all reports,
schedules, forms, statements and other documents required to be filed by it with the SEC under
the Exchange Act (all of the foregoing filed prior to the date hereof and all exhibits included
therein and

11NEXT PAGE

 financial statements and schedules thereto and documents incorporated by reference
therein, being hereinafter referred to as the "SEC Documents").  The Company has delivered to
the Investor or its representatives, or made available through the SEC's website at
http://www.sec.gov, true and complete copies of the SEC Documents.  As of their respective
dates, all of the financial statements of the Company disclosed in the SEC Documents (the
"Financial Statements") complied as to form in all material respects with applicable accounting
requirements and the rules and regulations of the SEC applicable thereto.  Such financial
statements have been prepared in accordance with generally accepted accounting principles,
consistently applied, during the periods involved (except (i) as may be otherwise indicated in
such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements,
to the extent they may exclude footnotes or may be condensed or summary statements) and fairly
present in all material respects the financial position of the Company as of the dates thereof and
the results of its operations and cash flows for the periods then ended (subject, in the case of
unaudited statements, to normal year-end audit adjustments).  No other information provided by
or on behalf of the Company to the Investor which is not included in the SEC Documents
contains any untrue statement of a material fact or omits to state any material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were
made, not misleading.

       Section 4.6       Disclosure.	None of the SEC Documents contain any untrue statements
of material fact, or omits to state any material fact required to be stated therein necessary to make
the statements made, in light of the circumstances under which they were made, not misleading.

       Section 4.7       No Default. Except as disclosed in Schedule 4.7, the Company is not in
default in the performance or observance of any material obligation, agreement, covenant or
condition contained in any indenture, mortgage, deed of trust or other material instrument or
agreement to which it is a party or by which it is or its property is bound.  Except as set forth in
Schedule 4.7, neither the execution, nor the delivery by the Company, nor the performance by
the Company of its obligations under this Agreement or any of the exhibits or attachments hereto
will conflict with or result in the breach or violation of any of the terms or provisions of, or
constitute a default or result in the creation or imposition of any lien or charge on any assets or
properties of the Company under its Certificate of Incorporation, By-Laws, any material
indenture, mortgage, deed of trust or other material agreement applicable to the Company or
instrument to which the Company is a party or by which it is bound, or any statute, or any
decree, judgment, order, rules or regulation of any court or governmental agency or body having
jurisdiction over the Company or its properties, in each case which default, lien or charge is
likely to cause a Material Adverse Effect on the Company's business or financial condition.

       Section 4.8       Absence of Events of Default.  Except as set forth in Schedule 4.7, no
event of default, as defined in the respective agreement to which the Company is a party, and no
event which, with the giving of notice or the passage of time or both, would become an event of
default (as so defined), has occurred and is continuing, which could or would have a material
adverse effect on the Company's business, properties, prospects, financial condition or results of
operations.

12NEXT PAGE

       Section 4.9       Intellectual Property Rights.   The Company and its subsidiaries own or
possess adequate rights or licenses to use all trademarks, trade names, service marks, service
mark registrations, service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and rights necessary to conduct their
respective businesses as now conducted.   The Company and its subsidiaries do not have any
knowledge of any infringement by the Company or its subsidiaries of trademark, trade name
rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks,
service mark registrations, trade secret or other similar rights of others, and, to the knowledge of
the Company, there is no claim, action or proceeding being made or brought against, or to the
Company's knowledge, being threatened against, the Company or its subsidiaries regarding
trademark, trade name, patents, patent rights, invention, copyright, license, service names,
service marks, service mark registrations, trade secret or other infringement; and the Company
and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the
foregoing.  

       Section 4.10       Employee Relations.  Neither the Company nor any of its subsidiaries is
involved in any labor dispute nor, to the knowledge of the Company or any of its subsidiaries, is
any such dispute threatened.  None of the Company's or its subsidiaries' employees is a member
of a union and the Company and its subsidiaries believe that their relations with their employees
are good.

       Section 4.11       Environmental Laws.   The Company and its subsidiaries are (i) in
compliance with any and all applicable foreign, federal, state and local laws and regulations
relating to the protection of human health and safety, the environment or hazardous or toxic
substances or wastes, pollutants or contaminants ("Environmental Laws"), (ii) have received all
permits, licenses or other approvals required of them under applicable Environmental Laws to
conduct their respective businesses and (iii) are in compliance with all terms and conditions of
any such permit, license or approval.

       Section 4.12       Title.  Except as set forth in Schedule 4.12, the Company has good and
marketable title to its properties and material assets owned by it, free and clear of any pledge,
lien, security interest, encumbrance, claim or equitable interest other than such as are not material
to the business of the Company.  Any real property and facilities held under lease by the
Company and its subsidiaries are held by them under valid, subsisting and enforceable leases
with such exceptions as are not material and do not interfere with the use made and proposed to
be made of such property and buildings by the Company and its subsidiaries.

       Section 4.13       Insurance.   The Company and each of its subsidiaries are insured by
insurers of recognized financial responsibility against such losses and risks and in such amounts
as management of the Company believes to be prudent and customary in the businesses in which
the Company and its subsidiaries are engaged.  Neither the Company nor any such subsidiary has
been refused any insurance coverage sought or applied for and neither the Company nor any such
subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be

13NEXT PAGE

necessary to continue its business at a cost that would not materially and adversely
affect the condition, financial or otherwise, or the earnings, business or operations of the
Company and its subsidiaries, taken as a whole.

       Section 4.14       Regulatory Permits.  The Company and its subsidiaries possess all
certificates, authorizations and permits issued by the appropriate federal, state or foreign
regulatory authorities necessary to conduct their respective businesses, and neither the Company
nor any such subsidiary has received any notice of proceedings relating to the revocation or
modification of any such certificate, authorization or permit.

       Section 4.15       Internal Accounting Controls.  The Company and each of its subsidiaries
maintains a system of internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management's general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management's general or specific
authorization and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences.

       Section 4.16       No Material Adverse Breaches, etc.  Except as set forth in the SEC
Documents, neither the Company nor any of its subsidiaries is subject to any charter, corporate
or other legal restriction, or any judgment, decree, order, rule or regulation which in the
judgment of the Company's officers has or is expected in the future to have a material adverse
effect on the business, properties, operations, financial condition, results of operations or
prospects of the Company or its subsidiaries.  Neither the Company nor any of its subsidiaries is
in breach of any contract or agreement which breach, in the judgment of the Company's officers,
has or is expected to have a material adverse effect on the business, properties, operations,
financial condition, results of operations or prospects of the Company or its subsidiaries.

       Section 4.17       Absence of Litigation.  Except as set forth in the SEC Documents, there is
no action, suit, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending against or affecting the
Company, the Common Stock or any of the Company's subsidiaries, wherein an unfavorable
decision, ruling or finding would (i) have a material adverse effect on the transactions
contemplated hereby (ii) adversely affect the validity or enforceability of, or the authority or
ability of the Company to perform its obligations under, this Agreement or any of the documents
contemplated herein, or (iii) except as expressly disclosed in the SEC Documents, have a
material adverse effect on the business, operations, properties, financial condition or results of
operation of the Company and its subsidiaries taken as a whole.

       Section 4.18       Subsidiaries.  Except as disclosed in the SEC Documents, the Company
does not presently own or control, directly or indirectly, any interest in any other corporation,
partnership, association or other business entity.

14NEXT PAGE

       Section 4.19       Other Outstanding Securities/Financing Restrictions.  Other than warrants
and options to acquire shares of Common Stock as disclosed in Schedule 4.3, there are no other
warrants and options registered with the SEC, which are available for sale as unrestricted ("free
trading") stock.

       Section 4.20       Tax Status.  The Company and each of its subsidiaries has made or filed
all federal and state income and all other tax returns, reports and declarations required by any
jurisdiction to which it is subject and (unless and only to the extent that the Company and each of
its subsidiaries has set aside on its books provisions reasonably adequate for the payment of all
unpaid and unreported taxes) has paid all taxes and other governmental assessments and charges
that are material in amount, shown or determined to be due on such returns, reports and
declarations, except those being contested in good faith and has set aside on its books provision
reasonably adequate for the payment of all taxes for periods subsequent to the periods to which
such returns, reports or declarations apply.  There are no unpaid taxes in any material amount
claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
know of no basis for any such claim.

       Section 4.21       Absence of Certain Developments. Except as provided in the SEC
Documents or on Schedule 4.21, since the date of the financial statement contained in the most
recently filed Form 10-KSB or 10-QSB, whichever is most current, neither the Company nor any
subsidiary has:

(i)	issued any stock, bonds or other corporate securities or any rights,
options or warrants with respect thereto;

(ii)	borrowed any amount or incurred or become subject to any
liabilities (absolute or contingent) except current liabilities incurred in the
ordinary course of business which are comparable in nature and amount to the
current liabilities incurred in the ordinary course of business during the
comparable portion of its prior fiscal year, as adjusted to reflect the current nature
and volume of the Company's or such subsidiary's business;

(iii)	discharged or satisfied any lien or encumbrance or paid any
obligation or liability (absolute or contingent), other than current liabilities paid in
the ordinary course of business;

(iv)	declared or made any payment or distribution of cash or other
property to stockholders with respect to its stock, or purchased or redeemed, or
made any agreements so to purchase or redeem, any shares of its capital stock;

(v)	sold, assigned or transferred any other tangible assets, or canceled
any debts or claims, except in the ordinary course of business;

(vi)	sold, assigned or transferred any patent rights, trademarks, trade
names, copyrights, trade secrets or other intangible assets or intellectual property

15NEXT PAGE

rights, or disclosed any proprietary confidential information to any person except
to customers in the ordinary course of business or to the Investor or its
representatives;

(vii)	suffered any material losses or waived any rights of material value,
whether or not in the ordinary course of business, or suffered the loss of any
material amount of prospective business;

(viii)	made any changes in employee compensation except in the
ordinary course of business and consistent with past practices;

(ix)	made capital expenditures or commitments therefor that aggregate
in excess of $50,000;

(x)	entered into any other material transaction, whether or not in the
ordinary course of business;

(xi)	suffered any material damage, destruction or casualty loss, whether
or not covered by insurance;

(xii)	experienced any material problems with labor or management in
connection with the terms and conditions of their employment; or

(xiii)	effected any two or more events of the foregoing kind which in the
aggregate would be material to the Company or its subsidiaries.

       Section 4.22       Certain Transactions.  Except as set forth in the SEC Documents, none of
the officers, directors, or employees of the Company is presently a party to any transaction with
the Company (other than for services as employees, officers and directors), including any
contract, agreement or other arrangement providing for the furnishing of services to or by,
providing for rental of real or personal property to or from, or otherwise requiring payments to or
from any officer, director or such employee or, to the knowledge of the Company, any
corporation, partnership, trust or other entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee or partner.

       Section 4.23       Fees and Rights of First Refusal.  Except as set forth in the SEC
Documents, the Company is not obligated to offer the securities offered hereunder or under the
Securities Purchase Agreement on a right of first refusal basis or otherwise to any third parties
including, but not limited to, current or former shareholders of the Company, underwriters,
brokers, agents or other third parties.

       Section 4.24       Use of Proceeds.  The Company represents that the net proceeds
from this offering will be used as provided on Schedule 4.24.  In no event shall the net proceeds
from this offering be used by the Company for the payment  (or loaned to any such person for
the payment) of

16NEXT PAGE

 any judgment, or other liability, incurred by any executive officer, officer,
director, or employee of the Company.

       Section 4.25       Further Representation and Warranties of the Company.  (a)  For
so long as any securities issuable hereunder held by the Investor remain outstanding, the
Company acknowledges, represents, warrants and agrees that it will use commercially reasonable
efforts to maintain the listing of its Common Stock on NASD Bulletin Board and/or the
NASDAQ Small Cap Stock Market and/or the American Stock Exchange.

              (b)	       The Company acknowledges and agrees that the Investor is acting solely
in the capacity of arm's length investor with respect to this Agreement and the transactions
contemplated hereunder. The Company further acknowledges that the Investor is not acting as a
financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this
Agreement and the transactions contemplated hereunder and any advice given by the Investor or
any of its representatives or agents in connection with this Agreement and the transactions
contemplated hereunder is merely incidental to the Investor's purchase of the shares of the
Common Stock to be purchased under this Agreement. The Company further represents to the
Investor that the Company's decision to enter into this Agreement has been based solely on the
independent evaluation by the Company and its own representatives and counsel.

       Section 4.26       Opinion of Counsel.  The Investor shall receive an opinion letter from
counsel to the Company (updated where applicable) on the date of this Agreement and on each
Advance Closing Date substantially in the form of Exhibit C.

       Section 4.27       Opinion of Counsel.  The Company will obtain for the Investor, at
the Company's expense, any and all opinions of counsel which may be reasonably required in
order to sell the securities issuable hereunder without restriction.

       Section 4.28       Dilution.  The Company is aware and acknowledges that issuance of
shares of the Company's Common Stock could cause substantial dilution to existing shareholders
and could significantly increase its issued and outstanding shares of Common Stock, thereby
exerting a negative effect on the trading price of the Common Stock.

ARTICLE V

Indemnification

       Section 5.1       Indemnification. (a) In consideration of the Investor's execution and
delivery of this Agreement, and in addition to all of the Company's other obligations under this
Agreement, the Company shall defend, protect, indemnify and hold harmless the Investor(s), and
all of their officers, directors, employees and agents (including, without limitation, those retained
in connection

17NEXT PAGE

with the transactions contemplated by this Agreement) (collectively, the "Investor
Indemnitees") from and against any and all actions, causes of action, suits, claims, losses, costs,
penalties, fees, liabilities and damages, and expenses in connection therewith (irrespective of
whether any such Investor Indemnitee is a party to the action for which indemnification
hereunder is sought), and including reasonable attorneys' fees and disbursements (the
"Indemnified Liabilities"), incurred by the Investor Indemnitees or any of them as a result of, or
arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty
made by the Company in this Agreement or the Registration Rights Agreement or any other
certificate, instrument or document contemplated hereby or thereby, (b) any breach of any
covenant, agreement or obligation of the Company contained in this Agreement or the
Registration Rights Agreement or any other certificate, instrument or document contemplated
hereby or thereby, or (c) any cause of action, suit or claim brought or made against such Investor
Indemnitee not arising out of any action or inaction of an Investor Indemnitee, and arising out of
or resulting from the execution, delivery, performance or enforcement of this Agreement or any
other instrument, document or agreement executed pursuant hereto by any of the Indemnitees.
To the extent that the foregoing undertaking by the Company may be unenforceable for any
reason, the Company shall make the maximum contribution to the payment and satisfaction of
each of the Indemnified Liabilities, which is permissible under applicable law.

              (a)       	In consideration of the Company's execution and delivery of this
Agreement, and in addition to all of the Investor's other obligations under this Agreement, the
Investor shall defend, protect, indemnify and hold harmless the Company and all of its officers,
directors, employees and agents (including, without limitation, those retained in connection with
the transactions contemplated by this Agreement) (collectively, the "Company Indemnitees")
from and against any and all Indemnified Liabilities incurred by the Indemnitees or any of them
as a result of, or arising out of, or relating to (a) any misrepresentation or breach of any
representation or warranty made by the Investor(s) in this Agreement or any instrument or
document contemplated hereby or thereby executed by the Investor, (b) any breach of any
covenant, agreement or obligation of the Investor(s) contained in this Agreement,  the
Registration Rights Agreement or any other certificate, instrument or document contemplated
hereby or thereby executed by the Investor, or (c) any cause of action, suit or claim brought or
made against such Company Indemnitee based on material misrepresentations or due to a
material breach by the Investor and arising out of or resulting from the execution, delivery,
performance or enforcement of this Agreement or any other instrument, document or agreement
executed pursuant hereto by any of the Company Indemnitees.  To the extent that the foregoing
undertaking by the Company may be unenforceable for any reason, the Company shall make the
maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities,
which is permissible under applicable law.

18NEXT PAGE

ARTICLE VI

Covenants of the Company

       Section 6.1       Registration Rights.  The Company shall cause the Registration Rights
Agreement to remain in full force and effect, and the Company shall comply in all material
respects with the terms thereof.

       Section 6.2       Listing of Common Stock.  The Company shall maintain the Common
Stock's authorization for quotation on the Over The Counter Bulletin Board.  

       Section 6.3       Exchange Act Registration.  The Company will cause its Common Stock
to continue to be registered under Section 12(g) of the Exchange Act, will file in a timely manner
all reports and other documents required of it as a reporting company under the Exchange Act
and will not take any action or file any document (whether or not permitted by Exchange Act or
the rules thereunder), to terminate or suspend such registration or to terminate or suspend its
reporting and filing obligations under said Exchange Act.

       Section 6.4       Transfer Agent Instructions.	Upon each Closing and the effectiveness of
the Registration Statement the Company will deliver instructions to its transfer agent to issue to
the Investor and deliver to the Escrow Agent shares of Common Stock free of legends.

       Section 6.5       Corporate Existence.  The Company will take all steps necessary to
preserve and continue the corporate existence of the Company.

       Section 6.6       Notice of Certain Events Affecting Registration; Suspension of Right to
Make an Advance.  The Company will immediately notify the Investor upon its becoming aware
of the occurrence of any of the following events in respect of a registration statement or related
prospectus relating to an offering of Registrable Securities: (i) receipt of any request for
additional information by the SEC or any other Federal or state governmental authority during
the period of effectiveness of the Registration Statement for amendments or supplements to the
registration statement or related prospectus; (ii) the issuance by the SEC or any other Federal or
state governmental authority of  any stop order suspending the effectiveness of the Registration
Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the
Registrable Securities for sale in any jurisdiction or the initiation or threatening of any
proceeding for such purpose; (iv) the happening of any event that makes any statement made in
the Registration Statement or related prospectus of any document incorporated or deemed to be
incorporated therein by reference untrue in any material respect or that requires the making of
any changes in the Registration Statement, related prospectus or documents so that, in the case of
the Registration Statement, it will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein
not misleading, and that in the case of the related prospectus, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading; and (v) the Company's reasonable determination that a post-effective
amendment to the Registration Statement would be appropriate; and the Company will promptly
make available to the Investor any such supplement or amendment

19NEXT PAGE

to the related prospectus.  The
Company shall not deliver to the Investor any Advance Notice during the continuation of any of
the foregoing events.

       Section 6.7       Expectations Regarding Advance Notices.  Within ten (10) days after the
commencement of each calendar quarter occurring subsequent to the commencement of the
Commitment Period, the Company must notify the Investor, in writing, as to its reasonable
expectations as to the dollar amount it intends to raise during such calendar quarter, if any,
through the issuance of Advance Notices.  Such notification shall constitute only the Company's
good faith estimate and shall in no way obligate the Company to raise such amount, or any
amount, or otherwise limit its ability to deliver Advance Notices.  The failure by the Company to
comply with this provision can be cured by the Company's notifying the Investor, in writing, at
any time as to its reasonable expectations with respect to the current calendar quarter.

       Section 6.8       Consolidation; Merger.  The Company shall not, at any time after the date
hereof, effect any merger or consolidation of the Company with or into, or a transfer of all or
substantially all the assets of the Company to another entity (a "Consolidation Event") unless the
resulting successor or acquiring entity (if not the Company) assumes all of the obligations of the
Company under this Agreement by written instrument satisfactory in form and substance to the
Investor, including the obligation to deliver to the Investor such shares of stock and/or securities
as the Investor is entitled to receive pursuant to this Agreement.   	

       Section 6.9       Issuance of the Company's Common Stock.  The sale of the shares of
Common Stock shall be made in accordance with the provisions and requirements of Regulation
D and any applicable state securities law.

ARTICLE VII

Conditions for Advance and Conditions to Closing

       Section 7.1       Conditions Precedent to the Obligations of the Company.  The obligation
hereunder of the Company to issue and sell the shares of Common  Stock  to the Investor
incident to each Advance Closing is subject to the satisfaction, or waiver by the Company, at or
before each such Advance Closing, of each of the conditions set forth below.

              (a)       Accuracy of the Investor's Representation and Warranties.  The
representations and warranties of the Investor shall be true and correct in all material respects as
of the date of this Agreement and as of the date of each such Advance Closing as though made at
each such time.

              (b)       Performance by the Investor.  The Investor shall have performed, satisfied
and complied in all respects with all covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Investor at or prior to such
Advance Closing.

20NEXT PAGE

       Section 7.2       Conditions Precedent to the Right of the Company to Deliver an Advance
Notice and the Obligation of the Investor to Purchase Shares of Common Stock.  The right of the
Company to deliver an Advance Notice and the obligation of the Investor hereunder to acquire
and pay for shares of the Company's Common Stock incident to an Advance Closing is subject
to the satisfaction or waiver by the Investor, on (i) the date of delivery of such Advance Notice
and (ii) the applicable Advance Closing Date (each a "Condition Satisfaction Date"), of each of
the following conditions:

              (a)       	Registration of the Common Stock with the SEC.  The Company shall
have filed the Registration Statement with the SEC and, subject to the requirements of the
Registration Rights Agreement, the Registration Statement shall have previously become
effective and shall remain effective on each Condition Satisfaction Date and (i) neither the
Company nor the Investor shall have received notice that the SEC has issued or intends to issue a
stop order with respect to the Registration Statement or that the SEC otherwise has suspended or
withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, or
intends or has threatened to do so (unless the SEC's concerns have been addressed and the
Investor is reasonably satisfied that the SEC no longer is considering or intends to take such
action), and (ii) no other suspension of the use or withdrawal of the effectiveness of the
Registration Statement or related prospectus shall exist.  The Registration Statement shall have
been declared effective by the SEC prior to the first Advance Notice Date.

              (b)       Authority.  The Company shall have obtained all permits and
qualifications required by any applicable state in accordance with the Registration Rights
Agreement for the offer and sale of the shares of Common Stock, or shall have the availability of
exemptions there from. The sale and issuance of the shares of Common Stock shall be legally
permitted by all laws and regulations to which the Company is subject.

              (c)       Accuracy of the Company's Representations and Warranties.  The
representations and warranties of the Company shall be true and correct as of each Condition
Satisfaction Date as though made at each such time (except for representations and warranties
specifically made as of a particular date) with respect to all periods, and as to all events and
circumstances occurring or existing to and including each Condition Satisfaction Date.

              (d)	       Performance by the Company.  The Company shall have performed,
satisfied and complied with all covenants, agreements and conditions required by this Agreement
and the Registration Rights Agreement to be performed, satisfied or complied with by the
Company at or prior to each Condition Satisfaction Date.

              (e)       No Injunction.  No statute, rule, regulation, executive order, decree, ruling
or injunction shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction that prohibits or directly and adversely affects
any of the transactions contemplated by this Agreement, and no proceeding shall have been
commenced that

21NEXT PAGE

may have the effect of prohibiting or adversely affecting any of the transactions
contemplated by this Agreement.

              (f)       Adverse Changes. Since the date of filing of the Company's most recent
SEC Document, there has occurred no event that had or is reasonably likely to have a Material
Adverse Effect.

              (g)	       No Suspension of Trading in or Delisting of Common Stock.  The trading
of the Common Stock is not suspended by the SEC or the Principal Market (if the Common
Stock is traded on a Principal Market).  The issuance of shares of Common Stock with respect to
the applicable Closing, if any, shall not violate the shareholder approval requirements of the
Principal Market (if the Common Stock is traded on a Principal market).  The Company shall not
have received any notice threatening the continued listing of the Common Stock on the Principal
Market (if the Common Stock is traded on a Principal Market).

              (h)       Maximum Advance Amount.  The amount of the advance requested by the
Company does not exceed the Maximum Advance Amount.

              (i)       No Knowledge.  The Company has no knowledge of any event more likely
than not to have the effect of causing such Registration Statement to be suspended or otherwise
ineffective.

              (j)       Other.  On each Condition Satisfaction Date, the Investor shall have
received and been reasonably satisfied with such other certificates and documents as shall have
been reasonably requested by the Investor in order for the Investor to confirm the Company's
satisfaction of the conditions set forth in this Section 7.2, including, without limitation, a
certificate executed by an executive officer of the Company contained in the Advance Notice.  

ARTICLE VIII

Due Diligence Review; Non-Disclosure of Non-Public Information

       Section 8.1       Due Diligence Review.  Prior to the filing of the Registration Statement
the Company shall make available for inspection and review by the Investor, its advisors and
representatives, any underwriter participating in any disposition of the Registrable Securities on
behalf of the Investor pursuant to the Registration Statement, any such registration statement or
amendment or supplement thereto or any blue sky, NASD or other filing, all financial and other
records, all SEC Documents and other filings with the SEC, and all other corporate documents
and properties of the Company as may be reasonably necessary for the purpose of such review,
and cause the Company's officers, directors and employees to supply all such information
reasonably requested by the Investor or any such representative, advisor or underwriter in
connection with such Registration Statement (including, without limitation, in response to all
questions and other inquiries reasonably made or submitted by any of them), prior to and from
time to time after the filing and

22NEXT PAGE

effectiveness of the Registration Statement for the sole purpose
of enabling the Investor and such representatives, advisors and underwriters and their respective
accountants and attorneys to conduct initial and ongoing due diligence with respect to the
Company and the accuracy of the Registration Statement.

       Section 8.2       Non-Disclosure of Non-Public Information.  

              (a)	       The Company shall not disclose non-public information to the Investor,
advisors to or representatives of the Investor unless prior to disclosure of such information the
Company identifies such information as being non-public information and provides the Investor,
such advisors and representatives with the opportunity to accept or refuse to accept such non-public information for review.  The Company may, as a condition to disclosing any non-public
information hereunder, require the Investor's advisors and representatives to enter into a
confidentiality agreement in form reasonably satisfactory to the Company and the Investor.

              (b)       Nothing herein shall require the Company to disclose non-public
information to the Investor or its advisors or representatives, and the Company represents that it
does not disseminate non-public information to any investors who purchase stock in the
Company in a public offering, to money managers or to securities analysts, provided, however,
that notwithstanding anything herein to the contrary, the Company will, as hereinabove provided,
immediately notify the advisors and representatives of the Investor and, if any, underwriters, of
any event or the existence of any circumstance (without any obligation to disclose the specific
event or circumstance) of which it becomes aware, constituting non-public information (whether
or not requested of the Company specifically or generally during the course of due diligence by
such persons or entities), which, if not disclosed in the prospectus included in the Registration
Statement would cause such prospectus to include a material misstatement or to omit a material
fact required to be stated therein in order to make the statements, therein, in light of the
circumstances in which they were made, not misleading.  Nothing contained in this Section 8.2
shall be construed to mean that such persons or entities other than the Investor (without the
written consent of the Investor prior to disclosure of such information) may not obtain non-public information in the course of conducting due diligence in accordance with the terms of this
Agreement and nothing herein shall prevent any such persons or entities from notifying the
Company of their opinion that based on such due diligence by such persons or entities, that the
Registration Statement contains an untrue statement of material fact or omits a material fact
required to be stated in the Registration Statement or necessary to make the statements contained
therein, in light of the circumstances in which they were made, not misleading.

23NEXT PAGE

ARTICLE IX

Choice of Law/Jurisdiction

       Section 9.1       Governing Law.  This Agreement shall be governed by and interpreted in
accordance with the laws of the State of New York without regard to the principles of conflict of
laws.  The parties further agree that any action between them shall be heard in New York City,
New York, and expressly consent to the jurisdiction and venue of the Supreme Court of New
York and the United States District Court for the Southern District of New York for the
adjudication of any civil action asserted pursuant to this paragraph.

ARTICLE X

Assignment; Termination

       Section 10.1       Assignment.  Neither this Agreement nor any rights of the Company
hereunder may be assigned to any other Person.  The provisions of this Agreement shall inure to
the benefit of, and be enforceable by, any transferee of the Investor.  The Investor's interest in
this Agreement may be assigned at any time, in whole or in part, to any other person or entity
(including any affiliate of the Investor) who agrees to make the representations and warranties
contained in Article III and who agrees to be bound by the covenants of Article V.

       Section 10.2       Termination.  The obligations of the Investor to make Advances under
Article II hereof  shall terminate on the last day of the Commitment Period.

ARTICLE XI

Notices

       Section 11.1       Notices.   Any notices, consents, waivers, or other communications
required or permitted to be given under the terms of this Agreement must be in writing and will
be deemed to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt,
when sent by facsimile, provided a copy is mailed by U.S. certified mail, return receipt
requested; (iii) three (3) days after being sent by U.S. certified mail, return receipt requested, or
(iv) one (1) day after deposit with a nationally recognized overnight delivery service, in each
case properly addressed to the party to receive the same.  The addresses and facsimile numbers
for such communications shall be:

24NEXT PAGE

              If to the Company, to:

              PACEL CORP.,

              8870 Rixlew Lane, Suite 201

              Manassas, VA 20109-3795

              Attention: David Calkins

              Telephone: (703) 257-4759

              Facsimile:  (703) 361-6706

	

       If to the Investor, to its address and facsimile number on Schedule I, with copies to the Investor's
counsel as set forth on Schedule I.  Each party shall provide five (5) days' prior written notice to the
other party of any change in address or facsimile number.

ARTICLE XII

Miscellaneous

       Section 12.1       Counterparts.   This Agreement may be executed in two (2) or more
identical counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other
party.  In the event any signature page is delivered by facsimile transmission, the party using
such means of delivery shall cause four (4) additional original executed signature pages to be
physically delivered to the other party within five (5) days of the execution and delivery hereof

       Section 12.2       Entire Agreement; Amendments.  This Agreement supersedes all other
prior oral or written agreements between the Investor(s), the Company, their affiliates and
persons acting on their behalf with respect to the matters discussed herein, and this Agreement
and the instruments referenced herein contain the entire understanding of the parties with respect
to the matters covered herein and therein and, except as specifically set forth herein or therein,
neither the Company nor any Investor makes any representation, warranty, covenant or
undertaking with respect to such matters.  No provision of this Agreement may be waived or
amended other than by an instrument in writing signed by the party to be charged with
enforcement.

       Section 12.3       Reporting Entity for the Common Stock.  The reporting entity relied upon
for the determination of the trading price or trading volume of the Common Stock on any given
Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor
thereto.  The written mutual consent of the Investor and the Company shall be required to
employ any other reporting entity.

       Section 12.4       Fees and Expenses.  The Company and Yorkville Advisors, LLC have
entered into that certain Placement Agent Agreement (the "Placement Agent Agreement"), dated
the date hereof, pursuant to which the Company as agreed to pay certain fees all as set forth
therein.

25NEXT PAGE

       Section 12.5       Legal Fees. 	Each of the parties shall pay its own fees and expenses
(including the fees of any attorneys, accountants, appraisers or others engaged by such party) in
connection with this Agreement and the transactions contemplated hereby, except that the
Company will pay the sum of Twenty-Five Thousand ($25,000) Dollars, to McGuireWoods LLP
for legal fees pursuant to the Securities Purchase Agreement, dated the date hereof, between the
Company and the buyers named therein.

       Section 12.6       Brokerage.  Each of the parties hereto represents that it has had no
dealings in connection with this transaction with any finder or broker who will demand payment
of any fee or commission from the other party, other than as set forth in the Placement Agency
Agreement. The Company on the one hand, and the Investor, on the other hand, agree to
indemnify the other against and hold the other harmless from any and all liabilities to any person
claiming brokerage commissions or finder's fees on account of services purported to have been
rendered on behalf of the indemnifying party in connection with this Agreement or the
transactions contemplated hereby.

       Section 12.7       Confidentiality.  If for any reason the transactions contemplated by this
Agreement are not consummated, each of the parties hereto shall keep confidential any
information obtained from any other party (except information publicly available or in such
party's domain prior to the date hereof, and except as required by court order) and shall promptly
return to the other parties all schedules, documents, instruments, work papers or other written
information without retaining copies thereof, previously furnished by it as a result of this
Agreement or in connection herein.

[Signature Page Follows]

26NEXT PAGE

		COMPANY
PACEL CORP.

By:_________________________________

Name:

Title:

INVESTOR
CORNELL CAPITAL PARTNERS, L.P.

By:_________________________________

Name:

Title:

27NEXT PAGE<PAGE>
                                                                    EXHIBIT 4.67

This Promissory Note has not been registered under the Securities Act of 1933,
as amended (the "Act"), or applicable state securities laws (the "State Acts"),
and shall not be sold, pledged, hypothecated, donated or otherwise transferred
(whether or not for consideration) by the holder except upon the issuance to
Tipperary Corporation of a favorable opinion of the holder's counsel or
submission to Tipperary Corporation of such other evidence as may be
satisfactory to counsel to Tipperary Corporation, to the effect that any such
transfer shall not be in violation of the Act and the State Acts.

                                PROMISSORY NOTE

$7,500,000                                                     Denver, Colorado
                                                              December 19, 2000

     Tipperary Corporation, a Texas corporation ("Maker"), hereby promises to
pay to the order of Slough Estates USA Inc., a Delaware corporation ("Lender"),
at its office located at 33 West Monroe Street, Suite 2000, Chicago, Illinois
60603, or at any other place the holder hereafter designates, the principal sum
of $7,500,000, together with interest thereon in lawful money of the United
States as herein provided.

     1.   Interest. The unpaid principal balance of this Note shall bear
          --------
interest commencing on the date all proceeds of the loan are received by Maker,
such interest to be at the three-month London Interbank Offered Rate ("LIBOR")
plus (i) 3.5% per year until such date as the unpaid principal balance of this
Note becomes due and payable and (ii) 6.0% per year after such date as the
unpaid principal balance of this Note becomes due and payable, whether at
maturity or pursuant to other default as provided hereunder; said interest rate
to be adjusted in accordance with changes to LIBOR at such times as LIBOR is
changed, payable in arrears in calendar quarterly installments; provided,
however, that the accrued but unpaid interest on the $6.5 Million Note, at the
time of the surrender and cancellation of the $6.5 Million Note as provided in
Section 8 below, shall be added to and included in the first such quarterly
installment.  Each such quarterly interest payment shall be due and payable
within five days of the end of each calendar quarter.  Interest shall be
calculated based on the actual number of days the principal balance remains
outstanding in a year of 365 days.

     2.   Maturity. The unpaid principal balance of this Note, together with
          --------
accrued and unpaid interest, shall be due and payable on March 31, 2003.

     3.   Security. This Note is secured by a security agreement dated December
          --------
22, 1998, as amended by that certain Amendment to Security Agreement, dated
March 11, 1999, and as further amended by that certain Second Amendment to
Security Agreement, of even date herewith, in favor of Lender.

     4.   Prepayment. The unpaid principal balance of the Note, together with
          ----------
accrued and unpaid interest, may be paid in whole or in part at any time in the
sole discretion of Maker without penalty.  Any prepayment in part by Maker shall
be first allocated to any accrued and unpaid interest, with any remaining amount
being allocated to the unpaid principal.

     5.   Default. If any of the following events occurs, all indebtedness owing
          -------
by Maker hereunder shall become forthwith due and payable to Lender, upon
delivery by Lender to Maker of a written notice of default and demand for
payment, and the expiration of the following periods from the delivery of such
notice, during which periods Maker shall have the ability to cure such default:
(i) in the case of (a) below, ten days, (ii) in the case of (b), (c) or (d)
below, 30 days and, (iii) in the case of (e) below, 15 days, or, if it is not
<PAGE>

practicable for Maker to cure such default within said 15-day period and Maker
is diligently proceeding to cure such default, such time longer than 15 days as
is reasonable for Maker to cure such default.

          (a)  Any default by Maker in the payment, when due, of any part of the
principal of or interest on this Note and the payment of any other sums payable
by Maker pursuant to the terms of this Note.

          (b)  The insolvency or bankruptcy of Maker or any of its direct or
indirect subsidiaries, the execution by Maker or any of its direct or indirect
subsidiaries of an assignment for the benefit of creditors of substantially all
of the assets of Maker or any such direct or indirect subsidiary, or Maker's or
any of its direct or indirect subsidiary's consent to the appointment of a
trustee or a receiver or other officer of a court or other tribunal.

          (c)  The appointment of a trustee or receiver or other officer of a
court for Maker or any of its direct or indirect subsidiaries, or for a
substantial part of their properties, without the consent of Maker or of such
direct or indirect subsidiary, where no discharge is effected within 30 days.

          (d)  The institution of bankruptcy, reorganization, insolvency, or
liquidation proceedings by or against Maker or any of its direct or indirect
subsidiaries, and if against Maker or such a direct or indirect subsidiary,
where such proceeding is consented to by Maker or such subsidiary or remains
undismissed for 30 days.

          (e)  Any breach or failure of Maker to perform any term or condition
of this Note.

     6.   Collection. Maker and all guarantors and endorsers of this Note shall
          ----------
pay all costs and expenses of collection and enforcement of this Note, including
reasonable attorneys' fees.

     7.   Waiver. Demand, presentment for payment, notice of dishonor, protest
          ------
and notice of protest are hereby waived.

     8.   Proceeds. The proceeds from this Note, to be given on and as of the
          --------
date of this Note, shall consist of (a) $1,000,000 in cash and (b) the
cancellation and surrender, by Lender to Maker, of a Promissory Note made by
Maker in favor of Lender, dated March 11, 1999, in the principal amount of
$6,500,000 (the "$6.5 Million Note"); provided, however, that accrued and unpaid
interest on the $6.5 Million Note shall be paid by Maker as provided in Section
1 above.  The $1,000,000 cash proceeds are to be used for the general corporate
purposes of Maker.

     9.   Assignment. This Note may not be assigned by Lender or Maker without
          ----------
the express written consent of the other party; provided, however, that Lender
may assign this Note to any of its affiliates without such consent.  Such an
affiliate, for purposes of this Section 9, is any person of which Lender owns
directly or indirectly more than 50% of the voting equity interests, or such
person as owns directly or indirectly more than 50% of the voting equity
interests of Lender.

     10.  Governing Law. This Note is made and is being executed in the State
          -------------
of Colorado, and the provisions hereof will be construed in accordance with the
laws of the State of Colorado.  Furthermore, Lender and Maker (and their lawful
assignees, successors and endorsers) further agree that in the event of default
this Note may be enforced in any court of competent jurisdiction in the States
of Colorado or Illinois, and they do hereby submit to such jurisdiction in the
States of Colorado or Illinois.
<PAGE>

     11.  Severability. Invalidation of any of the provisions of this Note
          ------------
shall not affect the remainder of this Note.

     12.  Amendment. This Note may not be amended or modified except by an
          ---------
instrument in writing signed by both parties.

     13.  Credit Agreement. The terms and conditions of this Note are subject
          ----------------
to the terms and provisions of a Credit Agreement among the Maker, Tipperary Oil
& Gas (Australia) Pty Ltd, Tipperary Oil & Gas Corporation, TCW Debt & Royalty
Fund VI, L.P. and TCW Asset Management Company, dated as of April 28, 2000 (a
copy of which has been provided to Lender) which terms and provisions thereof
are incorporated herein by reference.

                                        TIPPERARY CORPORATION

                                        By:    /s/ David L. Bradshaw
                                           -----------------------------------
                                               David L. Bradshaw, President and
                                               Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00023-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00023-of-00352.parquet"}]]